100 total views
Synchron, a company in the field of brain-computer interfaces, is said to have implanted its first device in a patient in the US earlier this month, surpassing Elon Musk’s Neuralink.
This startup implanted a 1.5-inch (about 3.81 cm) device into the brain of a patient with ALS syndrome at Mount Sinai West Medical Center in New York. York on July 6, according to Bloomberg. A spokesperson for Synchron did not immediately respond to a request for comment.
The device’s purpose is to allow patients to communicate – even if they have lost their mobility – using thoughts to send emails and messages. The Bloomberg report also says that Synchron has implanted the device in four patients in Australia, allowing them to use the implant in their brain to send WhatsApp messages and shop online.
Last year, the Australian-based startup received permission from the US Food and Drug Administration (FDA) to begin human trials on six American patients with hemiplegia. . In 2019, the company implanted its device in its first human patient in Melbourne, Australia.
Meanwhile, Neuralink has yet to receive FDA approval, although Elon Musk has predicted the company could begin human trials as early as 2020. Most recently, he said in 2021 that the company plans to start implanting its computer chips in people by 2022. The announcement comes after the billionaire and co-founder shared a video of a monkey playing a video game using the Use your mind through the Neuralink brain chip.
Earlier this year, Neuralink’s co-founder and former chairman, Max Hodak, revealed that he invested in Synchron after leaving Musk’s startup.
The Synchon and Neuralink implants are similarly effective. Both are designed to translate human thoughts into computer commands and could help improve the lives of patients with neurological conditions like Parkinson’s or ALS.
However, Musk’s goals for Neuralink seem a bit more ambitious. In the past, Musk has claimed that brain-machine interfaces can give humans “telepathic” powers and make humans symbiotic with artificial intelligence. He even calls the device “a Fitbit in your skull”. Fitbit is a famous American smartwatch brand.
But Neuralink and Synchron products have some key differences, which are size and installation. The Australian startup’s product can be inserted into a human skull without cutting into the skull, using a catheter that delivers the device through an arc-shaped vein into a blood vessel in the brain. This process requires up to two separate surgeries.
In contrast, Neuralink plans to create a device that is much smaller and more powerful, but requires the removal of part of the patient’s skull and the process will be done using a robot.
#brain #computer #startup #beat #Neuralink #implanting #device #patient